CLI Trading Statement Bullish

CLIENTELE LIMITED - Trading statement for the six-month period ended 31 December 2025

Clientèle Limited
Full analysis

What this filing means

Clientele expects a significant HEPS surge of up to 112% for the interim period, though statutory EPS will decline due to a high prior-year base from an acquisition gain.

Clientele is expecting its core operating profits (HEPS) to nearly double compared to last year, helped by a new acquisition. While their total profit number looks lower on paper, it is only because last year's results were artificially boosted by a one-time accounting gain from buying another company.

Bull case

  • Projected Headline Earnings per Share (HEPS) growth of between 92% and 112% (unrestated) or 43% and 63% (restated) indicates strong operational performance.
  • The Group maintains a sound solvency and liquidity position with continued strong positive cash flows.
  • First-time consolidation of the Emerald Life subsidiary adds a new inorganic growth driver to the financial results.
  • Strong technical momentum with the stock trading above 50-day and 200-day moving averages alongside an 8.63% dividend yield.

Bear case

  • Actual Earnings Per Share (EPS) is expected to decrease by 24% to 45% due to the high base effect of a prior bargain purchase gain.
  • Restatements of 2024 interim results due to IFRS 17 contract boundary reviews introduce accounting complexity.
  • The financial information is provisional and has not yet been reviewed or reported on by the Company's auditors.
  • Extremely high Price/Book ratio of 118.50x suggests the market may be overvaluing the equity relative to its net asset base.
View original SENS announcement

AI-generated summary by SENS-AI, based on the original JSE SENS filing.

SENS-AI conclusion

Clientele has issued a complex trading statement showing a stark divergence between surging HEPS (up 92-112%) and declining EPS (down 24-44%), primarily due to the non-recurrence of a bargain purchase gain from the 1Life acquisition. The underlying operational narrative is positive, bolstered by the first-time consolidation of Emerald Life and robust cash generation, which supports the current 8.63% dividend yield. While IFRS 17 restatements add some noise, the strong HEPS growth suggests the core insurance business is performing well at a reasonable 6.7x trailing P/E. Investor Takeaway: The 'headline' growth is the cleaner signal here, suggesting the stock remains an attractive yield play with fundamental momentum despite the high accounting P/B ratio.

Operational results are strong. Maintain positions to capture the dividend yield while monitoring the final audited interim results for IFRS 17 consistency.

Evidence from the filing

  • The Group anticipates a substantial increase in Headline Earnings per Share (HEPS) of between 92% and 112% (unrestated) or 43% and 63% (restated)

    “the Group's headline earnings per share ("HEPS") is expected to increase by between 92% and 112% resulting in an increase to between 98.41 cents and 108.66 cents, when compared to the HEPS of 51.25 cents for the Comparative Period. Similarly, the Group's HEPS is expected to increase by between 43% and 63% when compared to the restated HEPS of 67.51 cents for the Comparative Period.”
  • Clientele Limited explicitly states it "remains in a sound solvency and liquidity position"

    “The Group remains in a sound solvency and liquidity position and has continued to generate strong positive cash flows.”
  • The first-time consolidation of Emerald Life Proprietary (Limited) contributes to the Group's financial results

    “taking account of the above and the first-time consolidation of the newly acquired wholly owned subsidiary, Emerald Life Proprietary (Limited), ("Emerald")”
  • The Group's actual Earnings Per Share (EPS) is expected to decrease by 24%-44% (unrestated) or 25%-45% (restated)

    “the Group's earnings per share ("EPS") is expected to decrease by between 24% and 44% resulting in a decrease to between 119.22 cents and 87.85 cents, when compared to the EPS of 156.85 cents for the Comparative Period, as explained above. On a restated basis, the Group's EPS is expected to decrease by between 25% and 45% when compared to the restated EPS of 158.27 cents for the Comparative Period.”
  • The restatement of the 31 December 2024 interim financial results due to "changes to the application of IFRS 17"

    “various changes to the application of IFRS 17 were adopted primarily relating to a review of contract boundaries on a cohort of contracts, which resulted in the restatement of the 31 December 2024 interim financial results, which will be clearly explained in the full Interim Period results.”
  • The financial information in this trading statement has not been reviewed or reported on by auditors

    “The financial information on which this trading statement is based has not been reviewed or reported on by the Company's auditors.”
Category
Trading Statement
Published
Feb 23, 2026

More on Clientèle Limited

Related filings